Upgrade to SI Premium - Free Trial

Simulations Plus (SLP)

16.01 +0.10 (0.63%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/8/26)

Latest Headlines

Form 4 Simulations Plus, Inc. For: Jun 03 Filed by: DiBella John Anthony II June 4, 2026 4:07 PM - SEC Filing Form 4 Simulations Plus, Inc. For: Jun 01 Filed by: WOLTOSZ WALTER S June 2, 2026 4:07 PM - SEC Filing Form 144 Simulations Plus, Inc. Filed by: WOLTOSZ WALTER S June 1, 2026 4:33 PM - SEC Filing Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference May 21, 2026 4:05 PM - BizWire Form 4 Simulations Plus, Inc. For: May 11 Filed by: Fiedler-Kelly Jill May 13, 2026 4:08 PM - SEC Filing Form 144 Simulations Plus, Inc. Filed by: Fiedler-Kelly Jill May 11, 2026 4:35 PM - SEC Filing Simulations Plus partners with NVIDIA for AI drug development workflows May 6, 2026 7:55 AM - StreetInsider Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows May 6, 2026 7:55 AM - BizWire Form 4 Simulations Plus, Inc. For: May 04 Filed by: DiBella John Anthony II May 5, 2026 4:10 PM - SEC Filing Form 4 Simulations Plus, Inc. For: May 04 Filed by: WOLTOSZ WALTER S May 5, 2026 4:10 PM - SEC Filing Form 144 Simulations Plus, Inc. Filed by: WOLTOSZ WALTER S May 4, 2026 4:26 PM - SEC Filing Form 4 Simulations Plus, Inc. For: May 01 Filed by: Evans Sharlene May 1, 2026 4:07 PM - SEC Filing Form 4 Simulations Plus, Inc. For: May 01 Filed by: WOLTOSZ WALTER S May 1, 2026 4:07 PM - SEC Filing Form 4 Simulations Plus, Inc. For: May 01 Filed by: WEINER DANIEL L May 1, 2026 4:06 PM - SEC Filing Form 4 Simulations Plus, Inc. For: May 01 Filed by: Paglia John Kenneth May 1, 2026 4:06 PM - SEC Filing Simulations Plus teams with Lonza and FDA on drug prediction framework April 21, 2026 7:56 AM - StreetInsider Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products April 21, 2026 7:55 AM - BizWire Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School April 20, 2026 7:55 AM - BizWire Form 4 Simulations Plus, Inc. For: Apr 15 Filed by: DiBella John Anthony II April 16, 2026 4:09 PM - SEC Filing Form 144 Simulations Plus, Inc. Filed by: DiBella John Anthony II April 15, 2026 4:46 PM - SEC Filing Form 10-Q Simulations Plus, Inc. For: Feb 28 April 10, 2026 4:06 PM - SEC Filing Simulations Plus (SLP) PT Lowered to $16 at TD Cowen April 10, 2026 9:21 AM - StreetInsider Simulations Plus (SLP) Tops Q2 EPS by 4c, Offers Guidance April 9, 2026 4:07 PM - StreetInsider Form 8-K Simulations Plus, Inc. For: Apr 09 April 9, 2026 4:06 PM - SEC Filing Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results April 9, 2026 4:05 PM - BizWire Form SCHEDULE 13G/A Simulations Plus, Inc. Filed by: VANGUARD GROUP INC March 27, 2026 1:00 PM - SEC Filing Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date March 26, 2026 4:05 PM - BizWire Simulations Plus partners with pharma companies on AI drug development March 26, 2026 7:55 AM - StreetInsider Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling March 26, 2026 7:55 AM - BizWire Full Article List